About Resonant Pharmaceuticals
Resonant Pharmaceuticals is a company based in Ahmedabad (India) founded in 2014 by Jay Patel. It operates as a B2B. The company has 69 employees as of March 31, 2023. Resonant Pharmaceuticals offers products and services including Pharmaceutical Products, Contract Analytical Research, and Consulting Services. Resonant Pharmaceuticals operates in a competitive market with competitors including Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
- Headquarter Ahmedabad, India
- Employees 69 as on 31 Mar, 2023
- Founders Jay Patel
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Resonant Pharmaceuticals Private Limited
- Date of Incorporation 26 Nov, 2014
- Jurisdiction Navagam, Gujarat, India
-
Annual Revenue
$743.21 K (USD)53.52as on Mar 31, 2023
-
Net Profit
-$272.02 K (USD)51.5as on Mar 31, 2023
-
EBITDA
-$43.21 K (USD)81.59as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
69
as on Mar 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Resonant Pharmaceuticals
Resonant Pharmaceuticals offers a comprehensive portfolio of products and services, including Pharmaceutical Products, Contract Analytical Research, and Consulting Services.
Produces high-purity medicines and devices for global markets
Offers testing and consulting for pharmaceutical development needs
Provides expertise in regulatory compliance and product commercialization
Funding Insights of Resonant Pharmaceuticals
Detailed funding history for Resonant Pharmaceuticals
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Resonant Pharmaceuticals
Investment portfolio details for Resonant Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Resonant Pharmaceuticals
Detailed financials for Resonant Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Resonant Pharmaceuticals Comparisons
Peer comparison for Resonant Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Resonant Pharmaceuticals
Resonant Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Contract development and manufacturing organization for proprietary and generic drugs
|
|
| Locked | Locked | Locked |
CDMO focusing on spectrum of dosage forms and therapeutic segments
|
|
| Locked | Locked | Locked |
Company offering a suite of R&D and manufacturing services for small molecules and generics
|
|
| Locked | Locked | Locked |
Pharmaceutical development and manufacturing services are offered contractually.
|
|
| Locked | Locked | Locked |
CDMO with a focus on early phase drug product development
|
|
| Locked | Locked | Locked |
Cephalosporin APIs and generic formulations are manufactured.
|
Detailed competitors of Resonant Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Resonant Pharmaceuticals
Complete news archive for Resonant Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Resonant Pharmaceuticals
Resonant Pharmaceuticals was founded in 2014.
Resonant Pharmaceuticals is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.
As of Mar 31, 2023, the latest employee count at Resonant Pharmaceuticals is 69.
Annual revenue of Resonant Pharmaceuticals is $743.21K as on Mar 31, 2023.
Resonant Pharmaceuticals, based in Ahmedabad, India, specializes in producing high-quality pharmaceutical products through advanced manufacturing and rigorous testing. They provide contract analytical research, consulting, and development of new medicines and devices, ensuring WHO-GMP compliance. The company focuses on regulatory approval, global reach, and customer satisfaction by meeting international standards and environmental practices.
Resonant Pharmaceuticals's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Resonant Pharmaceuticals offers Pharmaceutical Products, Contract Analytical Research, and Consulting Services.